[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Sharma et al., 2020 - Google Patents

Diosgenin loaded polymeric nanoparticles with potential anticancer efficacy

Sharma et al., 2020

View HTML
Document ID
4140349231184682999
Author
Sharma N
Singhal M
Kumari R
Gupta N
Manchanda R
Syed A
Bahkali A
Nimesh S
Publication year
Publication venue
Biomolecules

External Links

Snippet

This study aims to determine the anticancer efficacy of diosgenin encapsulated poly-glycerol malate co-dodecanedioate (PGMD) nanoparticles. Diosgenin loaded PGMD nanoparticles (variants 7: 3 and 6: 4) were synthesized by the nanoprecipitation method. The synthesis of …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Similar Documents

Publication Publication Date Title
Wang et al. Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells
Rosman et al. Improved anticancer effect of magnetite nanocomposite formulation of gallic acid (Fe3O4-PEG-GA) against lung, breast and colon cancer cells
Łukasiewicz et al. Polycaprolactone nanoparticles as promising candidates for nanocarriers in novel nanomedicines
Zhou et al. pH-sensitive poly (β-amino ester) s nanocarriers facilitate the inhibition of drug resistance in breast cancer cells
Kim et al. Effective delivery of anti-cancer drug molecules with shape transforming liquid metal particles
Sharma et al. Diosgenin loaded polymeric nanoparticles with potential anticancer efficacy
Xia et al. Delivery of doxorubicin for human cervical carcinoma targeting therapy by folic acid-modified selenium nanoparticles
Kim et al. Glycol chitosan-docosahexaenoic acid liposomes for drug delivery: synergistic effect of doxorubicin-rapamycin in drug-resistant breast cancer
Chu et al. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers
Ma et al. Silymarin-loaded nanoparticles based on stearic acid-modified Bletilla striata polysaccharide for hepatic targeting
Khan et al. FMSP-nanoparticles induced cell death on human breast adenocarcinoma cell line (MCF-7 cells): morphometric analysis
Shah et al. Preparation, characterization, and pharmacological investigation of withaferin-A loaded nanosponges for cancer therapy; in vitro, in vivo and molecular docking studies
Di Natale et al. Tunable release of curcumin with an in silico-supported approach from mixtures of highly porous PLGA microparticles
Nasr et al. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles
Massadeh et al. Optimized polyethylene glycolylated polymer–lipid hybrid nanoparticles as a potential breast cancer treatment
Kim et al. Light-responsive polymeric micellar nanoparticles with enhanced formulation stability
Suresh et al. Development of a novel methotrexate-loaded nanoemulsion for rheumatoid arthritis treatment with site-specific targeting subcutaneous delivery
Paranthaman et al. Anti-proliferative potential of quercetin loaded polymeric mixed micelles on rat C6 and human U87MG glioma cells
Li et al. Hyaluronic acid-modified and doxorubicin-loaded gold nanoparticles and evaluation of their bioactivity
Zhu et al. Targeting pancreatic cancer cells with peptide-functionalized polymeric magnetic nanoparticles
Fule et al. Formulation, Optimization and Evaluation of Cytarabine-Loaded Iron Oxide Nanoparticles: From In Vitro to In Vivo Evaluation of Anticancer Activity
Andrýsková et al. Controlled release of tazarotene from magnetically responsive nanofiber patch: towards more efficient topical therapy of psoriasis
Massadeh et al. Development of epirubicin-loaded biocompatible polymer pla–peg–pla nanoparticles: Synthesis, characterization, stability, and in vitro anticancerous assessment
Xu et al. Stimuli-responsive micelles with detachable poly (2-ethyl-2-oxazoline) shell based on amphiphilic polyurethane for improved intracellular delivery of doxorubicin
Pramual et al. PLGA-lipid hybrid nanoparticles for overcoming paclitaxel tolerance in anoikis-resistant lung cancer cells